Partner With Us NRI

Apollo Hospitals Enterprise Ltd share Price Today

Company details

6M Return 7.65%
1Y Return 29.97%
Mkt Cap.(Cr) 85,039.48
Volume 608,807
Div Yield 0.25%
OI Chg %
Volume 608,807

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Stable numbers amid seasonality impact...
About The Stock

    Apollo is a leading integrated healthcare service provider.

    • Group capacity of 10006 beds across 71 hospitals in India. Total 9385 beds owned in 48 hospitals; 278 beds in 11 cradles; 244 beds in 11 day-care/short surgical stay centres; 851 beds in five hospitals under O&M contracts
    • It has got a digital presence with “ASK Apollo” & digital health platform “Apollo 24/7”. Apollo Hospitals is the exclusive supplier for APL, which operates India’s largest standalone pharmacy chain with 4529 outlets
    • Apollo Health & Lifestyle runs the largest chain of standardised primary healthcare models, multi-specialty clinics under the brand: Apollo Clinics in India and Middle East, diabetes management clinics: Apollo Sugar, diagnostic centres: Apollo Diagnostics, specialty formats: Apollo Cradle for women & children, Apollo Spectra for planned surgery

    Revenues were in line but margins were lower than estimated.

    • Revenues came in at ₹ 4263.6 crore, flat QoQ. Positive growth in pharmacy business was nullified by negative growth in healthcare (seasonality impact)
    • EBITDA corrected 10.6% QoQ to ₹ 505.4 crore. EBITDA margins declined 145 bps QoQ to 11.9% due to higher 24x7 and Esop charge
    • Adjusted net profit declined 25% QoQ to ₹ 153.6 crore

Click here for full recommendation

Research view on more stocks

Healthcare Facilities company Apollo Hospitals Enterprise announced Q3FY24 & 9MFY24 results:

Consolidated Q3FY24:

  • Revenues at Rs 48,506 million vs Rs 42,636 million in Q3FY23; growth of 14% YoY
  • EBITDA at Rs 6,137 million vs Rs 5,053 million in Q3FY23. This is after Apollo 247 cost of Rs 1,557 million in the quarter (including Rs 141 million non-cash ESOP charge) vs Rs 2,024 million in Q3 FY23.
  • Reported PAT at Rs 2,453 million vs Rs 1,535 million in Q3FY23
  • Diluted EPS of Rs 17.06 per share in Q3FY24 (not annualized)

Consolidated 9MFY24:

  • Revenue at Rs 141,153 million vs Rs123,103 million in 9MFY24; growth of 15% YoY
  • EBITDA at Rs 17,502 million vs Rs 15,615 million in 9MFY23. This is after Apollo 247 cost of Rs 5,569 million for 9M(including Rs 785 million non-cash ESOP charge) vs Rs 5,181 million in 9MFY23.
  • PAT stood at Rs 6,448 million vs Rs 5,315 million in 9MFY23
  • Reported PAT stood at Rs 6,448 million vs Rs 6,746 million in 9MFY23
  • Diluted EPS of Rs 44.84 per share in 9MFY24

Health Care service Q3FY24 Performance:

  • Revenue at Rs 24,635 million vs Rs 21,944 million in Q3 FY23; growth of 12% YoY
  • EBITDA grew by 8% at Rs 5,860 million vs Rs 5,428 million in Q3FY23; Margins at 23.8% in Q3FY24
  • PAT stood at Rs 2,872 million vs Rs 2,609 million in Q3FY23, 10% growth

Health Care service 9MFY24 Performance:

  • Revenue at Rs 73,044 million vs Rs 64,823 million in 9MFY23; growth of 13% YoY
  • EBITDA grew by 10% at Rs 17,627 million vs Rs 15,984 million in 9MFY23; Margins at 24.1% in 9MFY24
  • PAT stood at Rs 8,648 million vs Rs 9,043 million in 9MFY23

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, "In the pursuit of a healthier nation, Apollo remains steadfast in its belief in the importance of preventive healthcare. Our mission is to empower individuals to safeguard their well-being, preventing the onset of NonCommunicable Diseases (NCDs). In a country where 5.8 million lives are claimed annually by NCDs, and 1 in 4 Indians faces the risk of such an outcome before the age of 70, Apollo ProHealth emerges as a beacon of comprehensive personalized prevention. Combining medical expertise with Artificial Intelligence, this program, curated by skilled physicians, evaluates overall health, predicts risks, and guides individuals on a personalized path to wellness. It equips you with the tools and knowledge to make proactive choices for your well-being.

Our vision is resolute – to integrate preventive healthcare into the lives of every Indian. More than a business objective, it's a commitment to our nation's health. Together, let's strive to nurture countless healthy and happy families, shielding them from the growing threat of noncommunicable diseases.”

Result PDF

View Other Company Results

Apollo Hospitals Enterprise Ltd shares SWOT Analysis

Strengths (6)

  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt
  • Increasing Revenue every Quarter for the past 4 Quarters

Weakness (1)

  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (0)

Data not found

Threats (4)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 5,968.5
R2 6,022.6
R3 6,073.3


S1 5,863.6
S2 5,812.9
S3 5,758.8
Delivery and volume
AIA VCC - AIA ASIAN EQUITY FUND Block Purchase 2023-11-16 5311.25 22091 BSE
AIA INTERNATIONAL LIMITED Block Sell 2023-11-16 5311.25 22091 BSE
AIA VCC - AIA ASIAN EQUITY FUND Block Purchase 2023-10-19 5009.95 42216 BSE
Name Category Shares
Ms. Suneeta Reddy PROMOTER 3.36%
Ms. Sangita Reddy PROMOTER 1.69%
Ms. Shobana Kamineni PROMOTER 1.56%
Mr. K Vishweshwar Reddy PROMOTER 1.1%
Ms. Preetha Reddy PROMOTER 0.73%
M/s. PCR Investments Ltd PROMOTER 18.93%


Investment recommendation
Stable numbers amid seasonality impact...
Call Date
16 Feb 2023
Entry Price 4,487.00
Target Price 5,460.00
12-18 Month


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Apollo Hospitals Enterprise Ltd Stocks COMPARISON

Financials( in Cr) Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Global Health Ltd Narayana Hrudayalaya Ltd
Price 5,914.35 789.40 462.00 1,184.45 1,252.75
% Change -0.93 -1.70 -1.48 -1.44 -0.19
Mcap Cr 85,039.48 76,722.73 34,879.06 31,803.31 25,601.32
Revenue TTM Cr 16,612.50 4,831.37 6,537.06 2,694.25 4,524.77
Net Profit TTM Cr 887.50 1,103.51 632.98 326.08 606.57
PE TTM 108.28 72.57 59.43 66.45 33.16
1 Year Return 29.97 42.56 59.86 104.80 52.69
ROCE 14.16 13.85 7.51 16.49 29.27
ROE 15.04 16.12 6.79 16.13 33.51

Equity Capital: 6,197.40 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 29,248.28 -22,040.96
LAST 3M 102,638.29 -30,717.76
LAST 6M 167,920.74 50,623.85
LAST 12M 262,867.28 126,756.31

Apollo Hospitals Enterprise Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Apollo Hospitals Enterprise Ltd works in the Healthcare sector is having a market capitalization worth Rs. 68,247.55 crores, it was incorporated in the year 1983. It has reported consolidated sales of Rs. 2,867.95 crores in March’2021. The company is listed on the Bombay Stock Exchange (BSE) with the code 508869, and also listed on the National Stock Exchange (NSE) with the code APOLLOHOSP.

    Apollo Hospitals Enterprise Ltd is an Indian international hospital chain having its headquarters in Chennai, Tamil Nadu. Many of the Apollo Hospitals' hospitals have been among the country's first to receive an international healthcare certification from the Joint Commission International (JCI) and the National Accreditation Board for Hospitals and Healthcare Service Providers. Apart from the Hospital business, Apollo has established a presence in Pharmacies, Primary Care, and Diagnostics. Apollo hospitals has a national presence through an established network of over 70 hospitals and 3800 pharmacies spread across the country. The promoters of the company own 29.82% of the stake in the company, Foreign Institutional Investors (FII) own 53.23%, Domestic Institutional Investors (DII) own 11.08% stake in the company, and others (such as public & retail investors) hold the balance of 5.87%.

    In June 2021, quarterly net revenue was Rs. 2,994.71 crores, which has increased sharply by approximately 52.67 % from Rs. 1,961.52 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 150.04 crores, which has improved sharply and increased by nearly 200.62% from a net loss of Rs. 149.11 crores in June 2020. In June 2021, the reported operating profit was at Rs. 2,553.01 crores, which is also increased by 60.55% as compared to an operating profit of Rs. 1,590.2 crores for the quarter ending in June 2020. From a negative EPS of Rs. 10.72 in June 2020, the EPS of Apollo Hospitals Enterprises Ltd has improved and reached Rs. 10.44 per share in June 2021. APOLLOHOSP's stock closed at Rs. 4,746.50 on 20th August’2021 (NSE) and has given a return of 52.78% in the last six months and a return of 179.67% in the previous year.

Registered Address

No 19 Bishop Garden, Raja Annamalaipuram, Chennai, Tamil Nadu, 600028

Tel : 91-44-28290956/28293896
Email : investor.relations:apollohospitals.com
Website : http://www.apollohospitals.com

Integrated Registry Mgt Servic

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 508869
Book Closure Date (Month) :
BSE Group : A
ISIN : INE437A01024

FAQ’s on Apollo Hospitals Enterprise Ltd Shares

You can buy Apollo Hospitals Enterprise Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Apollo Hospitals Enterprise Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 24, 2024 03:57 PM the closing price of Apollo Hospitals Enterprise Ltd was Rs.5,914.35.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 24, 2024 03:57 PM, the market cap of Apollo Hospitals Enterprise Ltd stood at Rs. 85,039.48.

The latest PE ratio of Apollo Hospitals Enterprise Ltd as of May 24, 2024 03:57 PM is 108.28

The latest PB ratio of Apollo Hospitals Enterprise Ltd as of May 24, 2024 03:57 PM is 0.08

The 52-week high of Apollo Hospitals Enterprise Ltd share price is Rs. 6,874.45 while the 52-week low is Rs. 4,525.00

According to analyst recommendations, Apollo Hospitals Enterprise Ltd Share has a "Buy" rating for the long term.

Download App

Download Our App

Play Store App Store
market app